Original language | English |
---|---|
Pages (from-to) | 425-428 |
Journal | Journal of Rheumatology |
Volume | 35 |
Issue number | 3 |
Publication status | Published - 2008 |
IgM-rheumatoid factor, anti-cyclic citrullinated peptide, and anti-citrullinated human fibrinogen antibodies decrease during treatment with the tumor necrosis factor blocker infliximab in patients with rheumatoid arthritis
M. Vis, W.H. Bos, G. Wolbink, A.E. Voskuijl, J.W.R. Twisk, R van de Stadt, D. Hamann, B.A.C. Dijkmans, W.F. Lems
Research output: Contribution to Journal › Article › Academic › peer-review